Compile Data Set for Download or QSAR
Report error Found 53 of ic50 data for polymerid = 535
TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504403(US11040984, Compound 3)
Affinity DataIC50: 0.0200nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504412(US11040984, Compound 18)
Affinity DataIC50: 0.0500nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504411(US11040984, Compound 13)
Affinity DataIC50: 0.0520nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504415(US11040984, Compound 30)
Affinity DataIC50: 0.0520nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504414(US11040984, Compound 25)
Affinity DataIC50: 0.0690nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504408(US11040984, Compound 6)
Affinity DataIC50: 0.0700nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504410(US11040984, Compound 12)
Affinity DataIC50: 0.0850nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504413(US11040984, Compound 23)
Affinity DataIC50: 0.170nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504416(US11040984, Compound 33)
Affinity DataIC50: 0.290nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679677(US20240182487, Compound 76)
Affinity DataIC50: 2.20nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679672(US20240182487, Compound 71)
Affinity DataIC50: 2.40nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679671(US20240182487, Compound 70)
Affinity DataIC50: 2.90nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679675(US20240182487, Compound 74)
Affinity DataIC50: 4nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679679(US20240182487, Compound 78)
Affinity DataIC50: 5.30nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM391743(US10300058, Compound 28 | N-(3-((2-((2-methoxy-4-(...)
Affinity DataIC50: 5.5nMAssay Description:Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679658(US20240182487, Compound 1)
Affinity DataIC50: 6.80nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679696(US20240182487, Compound 97)
Affinity DataIC50: 9.70nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679692(US20240182487, Compound 93)
Affinity DataIC50: 13.6nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679664(US20240182487, Compound 63)
Affinity DataIC50: 14.9nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679685(US20240182487, Compound 86)
Affinity DataIC50: 15.6nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504402(US11040984, Compound 2)
Affinity DataIC50: 16.5nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679689(US20240182487, Compound 90)
Affinity DataIC50: 16.8nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679693(US20240182487, Compound 94)
Affinity DataIC50: 17.6nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679673(US20240182487, Compound 72)
Affinity DataIC50: 18.3nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679690(US20240182487, Compound 91)
Affinity DataIC50: 19.7nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679688(US20240182487, Compound 89)
Affinity DataIC50: 23.8nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679699(US20240182487, Compound 100)
Affinity DataIC50: 24nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679687(US20240182487, Compound 88)
Affinity DataIC50: 24.6nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679681(US20240182487, Compound 82)
Affinity DataIC50: 28.3nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679661(US20240182487, Compound 16)
Affinity DataIC50: 32.9nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679682(US20240182487, Compound 83)
Affinity DataIC50: 34.4nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679678(US20240182487, Compound 77)
Affinity DataIC50: 34.6nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679686(US20240182487, Compound 87)
Affinity DataIC50: 34.6nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679674(US20240182487, Compound 73)
Affinity DataIC50: 35.8nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM391742(US10300058, Compound 27 | N-(3-((2-((2-methoxy-4-(...)
Affinity DataIC50: 36nMAssay Description:Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679680(US20240182487, Compound 81)
Affinity DataIC50: 40.1nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679663(US20240182487, Compound 62)
Affinity DataIC50: 45.5nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679691(US20240182487, Compound 92)
Affinity DataIC50: 47.1nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679659(US20240182487, Compound 2)
Affinity DataIC50: 49.1nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679676(US20240182487, Compound 75)
Affinity DataIC50: 51nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM504405(US11040984, Compound 4)
Affinity DataIC50: 55.4nMAssay Description:Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679684(US20240182487, Compound 85)
Affinity DataIC50: 70nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679660(US20240182487, Compound 3)
Affinity DataIC50: 79nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679698(US20240182487, Compound 99)
Affinity DataIC50: 84.4nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679669(US20240182487, Compound 68)
Affinity DataIC50: 93.3nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679694(US20240182487, Compound 95)
Affinity DataIC50: 139nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679683(US20240182487, Compound 84)
Affinity DataIC50: 240nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679666(US20240182487, Compound 65)
Affinity DataIC50: 281nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679695(US20240182487, Compound 96)
Affinity DataIC50: 740nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetEpidermal growth factor receptor [1-745,751-1210](Human)
Medshine Discovery

US Patent
LigandPNGBDBM679697(US20240182487, Compound 98)
Affinity DataIC50: 836nMAssay Description:Biochemical Assays for Inhibition of Wild-Type and Mutant EGFRs.The inhibitory activities against EGFR WT, EGFR Δ752-759 mutant, EGFR Δ746-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: